Time since menopause and skeletal muscle estrogen receptors, PGC-1α, and AMPK
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Objective: Short-term administration of estradiol (E 2) improves insulin-stimulated glucose disposal rate in early postmenopausal (EPM) women compared with a reduction in late postmenopausal (LPM) women. The underlying mechanisms by which E 2 action on glucose disposal rate reversed from beneficial early to harmful late in menopause is unknown, but might include adverse changes in estrogen receptors (ERs) or other biomarkers of cellular energy metabolism with age or duration of estrogen deficiency. Methods: We retrospectively analyzed skeletal muscle samples from 27 postmenopausal women who were 6 years or less past menopause (EPM; n = 13) or at least 10 years past menopause (LPM; n = 14). Fasted skeletal muscle (vastus lateralis) samples were collected after 1 week administration of transdermal E 2 or placebo, in random cross-over design. Results: Compared with EPM, LPM had reduced skeletal muscle ERα and ERβ nuclear protein. Short-term E 2 treatment did not change nuclear ERα or ERβ, but decreased cytosolic ERα, so the proportion of ERα in the nucleus compared with the cytosol tended to increase. There was a group-by-treatment interaction (P < 0.05) for nuclear proliferator-activated receptor γ co-activator 1-α and phosphorylated adenosine monophosphate-activated protein kinase, such that E 2 increased these proteins in EPM, but decreased these proteins in LPM. Conclusions: These preliminary studies of skeletal muscle from early and late postmenopausal women treated with E 2 suggest there may be declines in skeletal muscle ER and changes in the E 2-mediated regulation of cellular energy homeostasis with increasing time since menopause.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Metabolic control through the PGC-1 family of transcription coactivators
Lin, J., Handschin, C., & Spiegelman, B. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.004 · Cited by 2,130
AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function
Hardie, D. G. (2011) · Genes & Development · doi:10.1101/gad.17420111 · Cited by 1,638
The Emergence of the Metabolic Syndrome with Menopause
Carr, M. C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030242 · Cited by 1,449 · cited 1×
“Our studies suggest estrogen-mediW production of ovarian hormones, predisposing them to metabolic dysregulation and development of type 2 diabetes.(1) Estrogen-based hormone therapy (HT) not only relieves vasomotor symptoms (eg, hot flashes, sleep disturbances),(2) but reduces incidence of diabetes in”
BackgroundDeFronzo, R. A., Gunnarsson, R., Björkman, O., Olsson, M., & Wahren, J. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111938 · Cited by 1,167
Regulation of mitochondrial biogenesis
Jornayvaz, F. R., & Shulman, G. I. (2010) · Essays in Biochemistry · doi:10.1042/bse0470069 · Cited by 1,119
Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes
Ritov, V. B., Menshikova, E. V., He, J., Ferrell, R. E., Goodpaster, B. H., & Kelley, D. E. (2005) · Diabetes · doi:10.2337/diabetes.54.1.8 · Cited by 887
Salpeter, S. R., Walsh, J. M. E., Ormiston, T. M., Greyber, E., Buckley, N. S., & Salpeter, E. E. (2006) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00545.x · Cited by 640 · cited 1×
“omen today live up to four decades without postmenopausal women.(3) Our studies suggest estrogen-mediW production of ovarian hormones, predisposing them to metabolic dysregulation and development of type 2 diabetes.”
BackgroundEstrogen Receptors and the Metabolic Network
Barros, R. P. A., & Gustafsson, J.-Å. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.005 · Cited by 458
Bryzgalova, G., Gao, H., Ahren, B., Zierath, J. R., Galuska, D., Steiler, T. L., Dahlman-Wright, K., Nilsson, S., Gustafsson, J.-Å., Efendic, S., et al. (2006) · Diabetologia · doi:10.1007/s00125-005-0105-3 · Cited by 384
Cited by
Estrogen as a key regulator of energy homeostasis and metabolic health
Mahboobifard, F., Pourgholami, M. H., Jorjani, M., Dargahi, L., Amiri, M., Sadeghi, S., & Tehrani, F. R. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113808 · Cited by 154
The role of estrogen in female skeletal muscle aging: A systematic review
Critchlow, A. J., Hiam, D., Williams, R., Scott, D., & Lamon, S. (2023) · Maturitas · doi:10.1016/j.maturitas.2023.107844 · Cited by 80
Hevener, A. L., Zhou, Z., Moore, T. M., Drew, B. G., & Ribas, V. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.06.013 · Cited by 72
Oosthuyse, T., Strauss, J. A., & Hackney, A. C. (2022) · European Journal of Applied Physiology · doi:10.1007/s00421-022-05090-3 · Cited by 70
The Impact of Skeletal Muscle ERα on Mitochondrial Function and Metabolic Health
Hevener, A. L., Ribas, V., Moore, T. M., & Zhou, Z. (2020) · Endocrinology · doi:10.1210/endocr/bqz017 · Cited by 54
Metadata
- Authors
- Park, Y.-M., Pereira, R. I., Erickson, C. B., Swibas, T. A., Kang, C., & Van Pelt, R. E.
- Venue
- Menopause
- Published
- 2017-07
- Volume
- 24
- Issue
- 7
- Pages
- 815-823
- ISSN
- 1072-3714 (ISSN-L)
- 1530-0374
- OpenAlex
- W2588973064
- Cited by
- 44
- References
- 17
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Time since menopause and skeletal muscle estrogen receptors, PGC-1α, and AMPK. https://app.cochat.ai/papers/10.1097/gme.0000000000000829
- The paper
- Park, Y.-M., Pereira, R. I., Erickson, C. B., Swibas, T. A., Kang, C., & Van Pelt, R. E. (2017). Time since menopause and skeletal muscle estrogen receptors, PGC-1α, and AMPK. Menopause. https://doi.org/10.1097/gme.0000000000000829
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.